Technical Analysis for ADVM - Adverum Biotechnologies, Inc.

Grade Last Price % Change Price Change
grade F 3.15 -1.25% -0.04
ADVM closed down 1.25 percent on Thursday, January 17, 2019, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ADVM trend table...

Date Alert Name Type % Chg
Jan 17 MACD Bearish Signal Line Cross Bearish 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 16 Fell Below 20 DMA Bearish -1.25%
Jan 16 180 Bearish Setup Bearish Swing Setup -1.25%
Jan 16 Outside Day Range Expansion -1.25%
Jan 15 Crossed Above 20 DMA Bullish -5.69%
Jan 15 Inside Day Range Contraction -5.69%
Jan 14 Fell Below 20 DMA Bearish -1.56%
Jan 14 Fell Below 50 DMA Bearish -1.56%

Older signals for ADVM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Adverum Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company is also developing AVA-201, a product candidate for the prevention of wet AMD; AVA-311 that is in preclinical studies for the treatment of juvenile X-linked retinoschisis, a rare genetic disease of the retina with no approved therapy; and AVA-322 and AVA-323 for the treatment of color vision deficiency. Avalanche Biotechnologies, Inc. has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was founded in 2006 and is headquartered in Menlo Park, California.
Is ADVM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.59
52 Week Low 2.62
Average Volume 465,795
200-Day Moving Average 5.1228
50-Day Moving Average 3.5136
20-Day Moving Average 3.308
10-Day Moving Average 3.411
Average True Range 0.2245
ADX 13.59
+DI 18.9531
-DI 25.3683
Chandelier Exit (Long, 3 ATRs ) 3.0265
Chandelier Exit (Short, 3 ATRs ) 3.4835
Upper Bollinger Band 3.6927
Lower Bollinger Band 2.9233
Percent B (%b) 0.29
BandWidth 23.258767
MACD Line -0.081
MACD Signal Line -0.0792
MACD Histogram -0.0019
Fundamentals Value
Market Cap 136.36 Million
Num Shares 43.3 Million
EPS -1.52
Price-to-Earnings (P/E) Ratio -2.07
Price-to-Sales 75.42
Price-to-Book 0.71
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.31
Resistance 3 (R3) 3.31 3.26 3.28
Resistance 2 (R2) 3.26 3.22 3.26 3.27
Resistance 1 (R1) 3.21 3.20 3.18 3.20 3.26
Pivot Point 3.16 3.16 3.15 3.16 3.16
Support 1 (S1) 3.10 3.12 3.08 3.10 3.04
Support 2 (S2) 3.05 3.09 3.05 3.03
Support 3 (S3) 3.00 3.05 3.02
Support 4 (S4) 2.99